INTRODUCTION
============

Cervical spondylotic myelopathy (CSM) is a major cause of disability in the United States \[[@b1-ns-1938198-099]\]. When compared to patients with other chronic debilitating diseases, those with CSM had a high rate of baseline disability and increased socioeconomic burden \[[@b1-ns-1938198-099]\]. It is estimated that 1.6 per 100,000 people have symptomatic CSM requiring surgery, and its incidence continues to rise with the aging patient population \[[@b2-ns-1938198-099],[@b3-ns-1938198-099]\]. The onset of symptoms is usually insidious, with patients experiencing a variety of different symptoms which may include neck pain with or without associated radiculopathy, decreased hand dexterity, gait imbalance, and bowel or bladder incontinence \[[@b4-ns-1938198-099],[@b5-ns-1938198-099]\]. Posterior cervical laminectomy and fusion (PCLF) remain a highly effective treatment strategy for patients with multi-level disease and significant dorsal compression. It may become even more utilized as the aging population demonstrates the increasing severity of cervical spondylosis \[[@b6-ns-1938198-099],[@b8-ns-1938198-099]\].

Complication rates for procedures that treat CSM are estimated to be about 10.4% overall, and the reported complication rates for PCLF are even greater, ranging from 12.5% to 16.9% in the existing literature \[[@b9-ns-1938198-099]-[@b12-ns-1938198-099]\]. Therefore, it is important to identify potential risk factors in order to optimize clinical outcomes. A recent study found that hypoalbuminemia, indicating malnutrition, was a significant risk factor for complication and prolonged length of stay following PCLF surgery \[[@b10-ns-1938198-099]\]. However, few others have examined potential predictors of complications associated with PCLF specifically \[[@b13-ns-1938198-099]\]. Our study seeks to identify potential risk factors for medical and surgical complications following PCLF surgery.

MATERIALS AND METHODS
=====================

1. Patient Population
---------------------

The electronic medical records of consecutive patients who underwent PCLF were reviewed from May 2012 through July 2018 at a single, high-volume academic spine center. Exclusion criteria included non-CSM diagnosis such as vertebral neoplasm or acute vertebral fracture, and patients who had concurrent or staged anterior cervical spine surgery. The perioperative records and imaging were reviewed and analyzed. Clinical records and imaging up to 3 months postoperatively were reviewed to identify adverse events. Medical research was conducted according to the World Medical Association Declaration of Helsinki. This study was approved by our Institutional Committee on Human Research as the Institutional Review Board of record (study \#18-24941). Patient consent was not required given that the only record linking the subject and the research would be the informed consent form and the principal risk of the present study is the potential harm resulting from a breach of confidentiality.

2. Data Collection
------------------

Demographic variables examined included age, sex, smoking status (current smoker or never/former smoker), insurance (private insurance, Medicare, Medicaid, or uninsured), revision surgery, and American Society of Anesthesiologists (ASA) physical status classification grades. Neurologic risk factors included an ambulation status (independent, assisted, or nonambulatory), primary indication for surgery (radiculopathy or myelopathy), and the presence of any motor deficit. Comorbidities examined included diabetes, coronary artery disease (CAD), psychiatric disorder, chronic renal disease, chronic pulmonary disease, arthritis of a major joint (shoulder, hip, or knee), and osteoporosis. Preoperative medications examined included muscle relaxants, antidepressants, antianxiety medication, and narcotic use. Preoperative medication use was defined as the presence of any active prescription at the time of surgery. Preoperative radiographic data examined included cervical lordosis, T1 slope, cervical sagittal vertical axis, chin-brow vertical angle, proximal junctional angle, distal junctional angle, sacral slope, pelvic incidence, pelvic tilt, lumbar lordosis, and thoracic kyphosis. All radiographic measurements were taken of sagittal plain film X-rays using eUnity software (ver. 6.3.0.1-4; Client Outlook Inc., Waterloo, ON, Canada). Measurements were made by 2 observers using radiographic parameters defined in previous literature \[[@b7-ns-1938198-099],[@b14-ns-1938198-099],[@b15-ns-1938198-099]\]. Interrater reliability, as measured by intraclass correlation, was 0.947 (95% confidence interval \[CI\], 0.943--0.951). Surgical characteristics examined included number of vertebrae fused, whether fusion crossed the cervicothoracic junction, estimated blood loss (EBL), operative time and whether laminectomy was performed, concurrently or in stages.

The primary outcome measured was the 30-day complication rate, defined as the proportion of patients who experienced an adverse event. This was refined further into 3 categories: medical complications, surgical complications, and overall complication. Medical complications included urinary tract infection (UTI), anemia, thrombotic events, arrhythmia, cardiac arrest, pneumonia, sepsis, and death. Surgical complications included dysphagia, durotomy, surgical site infection, seroma, new neurologic deficit, implant malposition, and surgical revision within 30 days. Overall complication was defined as the presence of a medical complication, a surgical complication, or both.

3. Statistical Analysis
-----------------------

Continuous risk factors are presented as means and standard deviations. Categorical risk factors are presented as the number of cases and percentages. Univariate analysis was used to identify predictors of postoperative complication. Chi-square, Fisher exact, and Student t-tests were performed and OR, 95% CI, and p-values were generated. Variables significant at p=0.20 were included in multivariate analysis. Patients with missing data for any included variable were omitted. A stepwise multivariate logistic regression was performed to examine each variable's relative contribution and calculate the adjusted OR, CI, and p-values. Statistical analyses were performed using custom scripts (RStudio software ver. 1.1.463; RStudio, Boston, MA, USA) running on Windows 10 Pro.

RESULTS
=======

1. Demographics
---------------

A total of 291 patients were initially identified from the electronic database. There were 81 patients excluded due to non-CSM diagnosis such as vertebral neoplasm or acute vertebral fracture, or other diagnoses unrelated to CSM, and another 14 patients were excluded due to concurrent or staged anterior cervical surgery. After applying the exclusion criteria, the perioperative records and imaging studies of the remaining 196 patients were reviewed and analyzed. Clinical records and imaging up to 3 months postoperatively were reviewed to identify adverse events.

The demographics of this cohort are provided in [Table 1](#t1-ns-1938198-099){ref-type="table"}. The mean age was 63±11.37 years, there were 90 female patients (45.9%) and 17 patients (8.7%) were smokers. There were 20 revision cases (10.2%), and 90 patients (45.9%) had ASA physical status classification grade of III or greater. Most patients ambulated independently (n=135, 68.9%), but many also had one or more motor deficit (n=132, 67.3%). The most common comorbidities were psychiatric disorders (n=69, 35.2%), diabetes (n=33, 16.8%), and arthritis (n=32, 16.3%). Approximately half of patients (n=101, 51.5%) reported preoperative narcotic use. Approximately 20% of patients had preoperative use of muscle relaxants (n=39, 19.9%), antidepressants (n=37, 18.9%), and antianxiety medications (n=34, 17.4%). Preoperative imaging showed an average cervical lordosis of 8.5°±14.6°, a T1 slope of 29.3°±10.9°, and a cervical sagittal vertebral axis (cSVA) of 33.8±17.6 mm. The average number of fused levels was 4.2±1.9, with a mean operative time of 221.4±97.7 minutes.

2. Postoperative Complications
------------------------------

The 30-day postoperative complication rates are shown in [Table 2](#t2-ns-1938198-099){ref-type="table"}. Medical complications occurred in 20 patients (10.2%), the most common of which were acute blood loss anemia (n=7, 3.6%), UTIs (n=5, 2.6%), and cardiac arrhythmias (n=4, 2.0%). Major medical complications occurred in 6 patients (3.1%), with 2 cases of pneumonia, one cardiac arrest, and one death within 30 days of surgery. Surgical complications occurred in 45 patients (23.0%). Of these, the most common complications included a new neurologic deficit following surgery (n=16, 8.2%), durotomy (n=11, 5.6%), and wound infections (n=7, 3.6%). Three patients (1.5%) had malpositioned implants or grafts and required revision surgery within 30 days. Overall, 57 patients (29.1%) experienced at least one medical or surgical complication.

3. Univariate Analysis
----------------------

Univariate analysis of risk factors for postoperative complications is presented in [Table 3](#t3-ns-1938198-099){ref-type="table"}. Significant predictors for medical complication included EBL over 500 mL (OR, 3.97; p=0.01), thoracic kyphosis (OR, 1.07; p=0.01), cSVA (OR, 1.03; p=0.04), and operative time (OR, 1.007; p=0.004). ASA physical status classification grade was not a significant predictor at the univariate level (OR, 2.25; p=0.09). There were no significant risk factors for surgical complication on univariate analysis. Overall complication incidence was predicted by EBL over 500 mL (OR, 2.91; p=0.01) operative time (OR, 1.004; p=0.03).

4. Multivariate Analysis
------------------------

Each multivariate regression model initially included all variables significant at p\<0.20 on univariate analysis and was iterated until only variables significant at p\<0.05 remained. Potential risk factors for medical complications included ambulation status, indication for surgery, several comorbidities (diabetes, CAD, psychiatric disorders, osteoporosis), preoperative antidepressant use, ASA score, cSVA, lumbar lordosis, thoracic kyphosis, length of fusion, EBL, and operative time ([Table 4](#t4-ns-1938198-099){ref-type="table"}). Of these, ambulation status (OR, 2.27; p=0.02), EBL over 500 mL (OR, 3.67; p=0.02), and thoracic kyphosis (OR, 1.08; p=0.004) emerged as significant predictors. Impaired ambulation was significantly associated with increased incidence of postoperative UTI (p=0.004) ([Supplementary Table 1](#SD1-ns-1938198-099){ref-type="supplementary-material"}) and EBL greater than 500 mL was associated with acute anemia (p=0.006, [Supplementary Table 2](#SD2-ns-1938198-099){ref-type="supplementary-material"}).

Variables included in the surgical complication model included smoking, CAD, osteoporosis, preoperative antidepressant and narcotic use, cSVA, thoracic kyphosis, EBL, and operative time. Of these, preoperative narcotic use (OR, 2.43; p=0.02) and operative time (OR, 1.005; p=0.03) were risk factors for surgical complication, whereas preoperative antidepressant use (OR, 0.21; p=0.01) was a protective factor ([Table 5](#t5-ns-1938198-099){ref-type="table"}). More specifically, operative time was significantly associated with increased incidence of dysphagia (p=0.01) ([Supplementary Table 3](#SD3-ns-1938198-099){ref-type="supplementary-material"}). Independent risk factors for overall postoperative complication were narcotic use (OR, 1.97; p=0.04) and EBL (OR, 1.0007; p=0.03) ([Table 6](#t6-ns-1938198-099){ref-type="table"}), the latter of which was associated with new postoperative neurologic deficit (p=0.02) ([Supplementary Table 2](#SD2-ns-1938198-099){ref-type="supplementary-material"}).

DISCUSSION
==========

The present study utilized a retrospective chart review to identify pre- and intraoperative predictors of complication following PCLF surgery. We found statistically significant associations between medical complications and impaired preoperative ambulation status, and increased EBL, and increased preoperative thoracic kyphosis. Surgical complication was associated with preoperative narcotic use and increased operative time. Finally, patients with preoperative narcotic use and intraoperative blood loss \>500 mL had statistically significant increased odds of overall complication following PCLF surgery.

The overall complication rate of 29.1% in this study is higher than those previously reported in the literature \[[@b9-ns-1938198-099],[@b11-ns-1938198-099],[@b12-ns-1938198-099],[@b16-ns-1938198-099],[@b17-ns-1938198-099]\]. This is mainly due to the expanded definition of "complication" used in our study compared to that of the NSQIP database, which is utilized in many previous studies \[[@b18-ns-1938198-099]\]. We included minor medical complications such as UTI, postoperative anemia, transient cardiac arrhythmia, and other surgical complications inherent to spinal surgery such as incidental durotomy and transient dysphagia were also included. In addition, new neurological deficits in this study included postoperative numbness and transient worsening weakness, which usually improved overtime. Excluding these minor complications from the analysis, the overall complication rate would decrease to 9.8%, which would be consistent with previously reported complication rates in the literature.

Ambulation status was found to be an important predictor for medical complications, in which patients with impaired preoperative ambulation status had 2.27 times greater odds of medical complication compared to those who ambulated independently (p=0.02) and was associated with a greater incidence of postoperative UTIs specifically (p=0.004). This finding is supported by a previous study, which had found that preoperative walking disabilities were associated with increased risk of venous thromboembolic events following spine surgery \[[@b19-ns-1938198-099]\]. The impaired ambulation status can be a consequence of CSM, but it may also be an indicator for patient frailty \[[@b16-ns-1938198-099],[@b20-ns-1938198-099]\]. The observed relationship between ambulatory status and UTIs may be explained by several mechanisms. Patients with significant CSM causing impaired ambulation are often observed to have neurogenic bladder symptoms associated with their condition as well. Though the goal of PCF surgery is to relieve cord compression and, therefore, bladder dysfunction, in some cases incomplete decompression can lead to continuation of preoperative symptoms. Alternatively, prior work has shown that poor mobility is itself associated with UTIs by allowing patients to independently void and decrease periods of urinary stasis, which is a predisposing factor to infection \[[@b21-ns-1938198-099]\]. Furthermore, patients with impaired mobility are more likely to have urinary catheter for longer periods of time, which may also increase the risk of UTI. Thus, loss of independent ambulation may serve as a predictor of postoperative complications and poor outcomes, establishing its importance as a potentially modifiable risk factor. "Prehabilitation" programs, which seek to improve surgical outcomes by providing preoperative physical and nutritional therapy to frail patients, may be an apt intervention to address the increased risk conferred by loss of mobility.

EBL is a well-established risk factor for perioperative complication in spine surgery \[[@b4-ns-1938198-099],[@b22-ns-1938198-099],[@b23-ns-1938198-099]\]. Our study supports this association, finding that EBL \>500 mL is associated with more than threefold greater odds of medical complication (p=0.02). Increased EBL was also associated with a small, but statistically significant increase in the odds of overall complication (p=0.03). Blood loss may lead to adverse events through a variety of pathways, from fluid shifts affecting cardiac, pulmonary, and renal status to impairment of the immune system leading to postoperative infections \[[@b24-ns-1938198-099]\]. The association found in this study between larger blood loss and acute anemia is evident, however the observed relationship with new neurologic deficits after surgery is less obvious. For some patients, EBL may serve as a proxy for invasiveness and complexity of surgery, which could predispose patients to nerve injury and associated deficits. This result suggests that minimizing EBL may help to decrease postoperative complications \[[@b25-ns-1938198-099]\].

Preoperative narcotic use was identified as an important predictor of postoperative complications in our study. One previous study found that narcotic use was not associated with complications up to 90 days after surgery \[[@b26-ns-1938198-099]\]. However, a recent retrospective database analysis by Jain et al. \[[@b27-ns-1938198-099]\] reported that preoperative opioid use was associated with an eightfold increase in odds of complication following posterior lumbar fusion surgery. The present study lends support to the latter finding, which may be explained through several biological mechanisms. Activation of cutaneous opioid receptors has been shown to interfere with angiogenesis, delay and reduce neutrophil and macrophage recruitment to the surgical site, and alter neuropeptide signaling that is essential for wound healing \[[@b28-ns-1938198-099]-[@b30-ns-1938198-099]\]. The difference in effect size (OR of 2.43 for surgical complication and 1.97 for overall complication, versus 8.08 in previous work) may be attributed to a shorter follow-up time capturing fewer complications in narcotic-using patients in our study (30 days versus 90 days). This likely explains the lack of significant associations with specific postoperative complications as well. For example, the incidence of surgical site infection was greater in the narcotic use group and, though this finding is supported by our mechanistic understanding of wound healing, it did not reach significance ([Supplementary Table 4](#SD4-ns-1938198-099){ref-type="supplementary-material"}).

Antidepressant use was the only protective factor for surgical complication identified. Depression and anxiety have well-documented associations with poor outcomes after spine surgery, having been shown to lead to increased Nurick scores and rates of delirium \[[@b31-ns-1938198-099],[@b32-ns-1938198-099]\]. Prior research has revealed that treatment of these disorders with antidepressants attenuates this increase in complications \[[@b33-ns-1938198-099]\]. This finding highlights the importance of preoperative treatment of psychiatric conditions.

Several other risk factors previously linked to postoperative complication were not found to be independent predictors in this study. While diabetes is often identified as a modifiable risk factor with a significant role in the incidence of complication, it did not emerge as a significant predictor in the univariate or multivariate analysis here \[[@b34-ns-1938198-099]-[@b36-ns-1938198-099]\]. Likewise, many studies cite body mass index (BMI) as an independent predictor of surgical site infection, though recent work has repudiated this finding \[[@b37-ns-1938198-099]-[@b40-ns-1938198-099]\]. In this study, BMI was included in the multivariate models for medical and overall complication, but its independent contribution was found to be insignificant (p=0.33 and p=0.98, respectively).

The present study has several limitations. As a retrospective study relying on chart review for data collection, it is subject to errors in the medical charts (i.e., missed diagnoses) and to the interpretation of the information therein. Underestimation of complications is another concern, as patients may seek care elsewhere within 30 days of surgery. Finally, our definition of preoperative opioid use did not include the actual dose information and is thus an incomplete metric of the extent of patients' actual opioid use.

CONCLUSION
==========

Preoperative narcotic use and impaired ambulation were identified as modifiable risk factors for complications after PCLF. Preoperative "Opioid-weaning" and "Prehabilitation" programs may help to reduce postoperative complications. Increased EBL and operative time also increased the odds of short-term complications after surgery. Spine surgeons should keep these results in mind when counseling patients regarding risks associated with PCLF.
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SUPPLEMENTARY MATERIALS
=======================

Supplementary Tables 1-4 can be found via <https://doi.org/10.14245/ns.1938198.099>.

###### 

Medical complications associated with impaired ambulation

###### 

Medical and overall complications associated with estimated blood loss

###### 

Surgical complications associated with operative time

###### 

Surgical and overall complications associated with preoperative narcotic use

###### 

Patient demographics

  Demographic                            Value
  -------------------------------------- ----------------
  Age (yr)                               63 ± 11.37
  Female sex                             90 (45.9)
  Current smoker                         17 (8.7)
  Insurance                              
   Medicare                              110 (56.1)
   Medicaid                              24 (12.2)
   Private Insurance                     90 (45.9)
   Uninsured                             2 (1.0)
  Revision surgery                       20 (10.2)
  ASA grade III+                         90 (45.9)
  Neurologic                             
   Ambulatory status                     
    Independent                          135 (68.9)
    Assisted                             36 (18.4)
    Nonambulatory                        25 (12.7)
   Indication for surgery                
    Radiculopathy                        28 (14.3)
    Myelopathy                           155 (79.1)
    Cervical instability                 12 (6.1)
    Motor deficit                        132 (67.3)
  Comorbidities                          
   Diabetes                              33 (16.8)
   CAD                                   14 (7.1)
   Psychiatric disorder                  69 (35.2)
   Chronic renal disease                 12 (6.1)
   Chronic pulmonary disease             21 (10.7)
   Arthritis                             32 (16.3)
   Osteoporosis                          20 (10.2)
  Preoperative medications               
   Muscle relaxants                      39 (19.9)
   Antidepressant                        37 (18.9)
   Antianxiety                           34 (17.3)
   Narcotics                             101 (51.5)
  Preoperative radiographic parameters   
   Cervical lordosis (°)                 8.53 ± 14.61
   T1 slope (°)                          29.37 ± 10.86
   cSVA (mm)                             33.82 ± 17.61
   Chin-brow vertical angle (°)          1.94 ± 8.79
   Proximal junctional angle (°)         -34.25 ± 18.53
   Distal junctional angle (°)           0.09 ± 6.44
   Sacral slope (°)                      38.12 ± 11.84
   Pelvic incidence (°)                  58.89 ± 14.46
   Pelvic tilt (°)                       21.70 ± 11.98
   Lumbar lordosis (°)                   48.792 ± 15.82
   Thoracic kyphosis (°)                 31.31 ± 11.64
   SVA (mm)                              37.73 ± 40.92
  Procedure                              
   Laminectomy performed                 184 (93.9)
   No. of vertebrae fused                4.2 ± 1.9
   EBL over 500 mL                       28 (14.3)
   Operative time (min)                  221.4 ± 97.7

Values are presented as mean±standard deviation or number (%).

ASA, American Society of Anesthesiologists physical status classification; CAD, coronary artery disease; cSVA, cervical sagittal vertical axis; SVA, sagittal vertical axis; EBL, estimated blood loss.

###### 

Incidence of 30-day complications

  Complication                                                    No. (%)
  --------------------------------------------------------------- -----------
  Medical complications                                           
   Minor                                                          18 (9.2)
    Urinary tract infection                                       5 (2.6)
    Anemia                                                        7 (3.6)
    Excessive blood loss (\> 3 L)                                 1 (0.5)
    Pneumothorax                                                  0 (0)
    Deep vein thrombosis                                          3 (1.5)
    Arrhythmia^[\*](#tfn1-ns-1938198-099){ref-type="table-fn"}^   4 (2.0)
   Major                                                          6 (3.1)
    Myocardial infarction                                         0 (0)
    Cardiac arrest                                                1 (0.5)
    Pneumonia                                                     2 (1.0)
    Pulmonary embolism                                            1 (0.5)
    Cerebrovascular event                                         1 (0.5)
    Sepsis                                                        1 (0.5)
    Death                                                         1 (0.5)
   Any medical complication                                       20 (10.2)
  Surgical complications                                          
   Minor                                                          39 (19.9)
    Dysphagia                                                     5 (2.6)
    Vocal cord paralysis                                          1 (0.5)
    Pain control                                                  4 (2.0)
    Durotomy                                                      11 (5.6)
    Superficial wound infection                                   4 (2.0)
    Cerebrospinal fluid leak                                      0 (0)
    Seroma                                                        5 (2.6)
    Wound dehiscence                                              0 (0)
    New neurologic deficit (weakness, palsy, numbness)            16 (8.2)
   Major                                                          8 (3.8)
    Deep wound infection                                          3 (1.5)
    Implant/graft malposition                                     3 (1.5)
    Wrong level surgery                                           0 (0)
    Pseudomeningocele                                             0 (0)
    Revision required within 30 days                              3 (1.5)
   Any surgical complication                                      45 (23.0)
  Any medical or surgical complication                            57 (29.1)

Arrhythmia includes atrial fibrillation, premature atrial contraction, premature ventricular contraction, and sinus tachycardia.

###### 

Univariate analysis of predictors of 30-day complications

  Variable                               Medical complication            OR (95% CI)              p-value               Surgical complication   OR (95% CI)           p-value              Any complication    OR (95% CI)          p-value                                       
  -------------------------------------- ------------------------------- ------------------------ --------------------- ----------------------- --------------------- -------------------- ------------------- -------------------- ------------------------- ------------------- ------
  Demographics                                                                                                                                                                                                                                                                    
                                         Age (yr)                                                                                                                                                                                                                                 
                                                                         \< 65                    9 (8.4)               Ref                     Ref                   24 (22.4)            Ref                 Ref                  29 (2.1)                  Ref                 Ref
                                                                         ≥ 65                     11 (12.4)             1.02 (0.98--1.06)       0.43                  21 (23.6)            1.01 (0.98--1.04)   0.61                 28 (31.5)                 1.01 (0.99--1.04)   0.38
                                         Sex                                                                                                                                                                                                                                      
                                                                         Male                     14 (13.2)             Ref                     Ref                   25 (23.6)            Ref                 Ref                  34 (32.1)                 Ref                 Ref
                                                                         Female                   6 (6.7)               0.47 (0.16--1.23)       0.14                  20 (20.2)            0.93 (0.47--1.80)   0.43                 23 (25.6)                 0.73 (0.39--1.35)   0.32
                                         Smoking status                                                                                                                                                                                                                           
                                                                         Never or former smoker   20 (11.5)             Ref                     Ref                   35 (20.1)            Ref                 Ref                  47 (27.0)                 Ref                 Ref
                                                                         Current smoker           0 (0)                 N/A                     N/A                   6 (35.3)             2.17 (0.71--6.11)   0.14                 6 (35.3)                  1.47 (0.48--4.10)   0.54
  Medicare                               13 (11.8)                       1.51 (0.59--4.19)        0.40                  28 (25.5)               1.39 (0.71--2.78)     0.62                 34 (30.9)           1.23 (0.66--2.31)    0.52                                          
  Medicaid                               2 (8.3)                         0.78 (0.12--2.95)        0.75                  5 (20.8)                0.87 (0.27--2.32)     0.55                 7 (29.2)            1.00 (0.36--2.48)    0.99                                          
  Private insurance                      9 (10.0)                        0.96 (0.37--2.43)        0.93                  19 (21.1)               0.82 (0.42--1.61)     0.65                 25 (27.8)           0.89 (0.48--1.65)    0.71                                          
  Uninsured                              0 (0)                           0 (0--NaN)               1                     1 (50.0)                3.41 (0.13--87.39)    0.36                 1 (50.0)            2.46 (0.10--63.04)   0.53                                          
  Revision surgery                                                                                                                                                                                                                                                                
                                         No                              17 (9.7)                 Ref                   Ref                     39 (22.3)             Ref                  Ref                 51 (29.1)            Ref                       Ref                 
                                         Yes                             3 (15.0)                 1.64 (0.36--5.54)     0.46                    6 (30.0)              1.49 (0.50--4.00)    0.69                6 (30.0)             1.04 (0.35--2.75)         0.94                
  ASA grade                                                                                                                                                                                                                                                                       
                                         \< III                          7 (6.6)                  Ref                   Ref                     23 (21.7)             Ref                  Ref                 28 (26.4)            Ref                       Ref                 
                                         III+                            13 (14.4)                2.25 (0.90--6.19)     0.09                    22 (24.4)             1.07 (0.56--2.06)    1                   29 (32.2)            1.21 (0.67--2.23)         0.53                
  Neurologic                                                                                                                                                                                                                                                                      
                                         Ambulatory status                                        1.65 (0.91--2.90)     0.09                                          1.07 (0.66--1.68)    0.73                                     1.21 (0.79--1.84)         0.38                
                                                                         Independent              10 (7.4)                                                            29 (21.5)                                                     36 (26.7)                                     
                                                                         Assisted                 6 (16.7)                                                            11 (30.6)                                                     13 (36.1)                                     
                                                                         Nonambulatory            4 (16.0)                                                            5 (20.0)                                                      8 (32.0)                                      
                                         Indication for surgery                                   2.21 (0.78--6.58)     0.15                                          1.17 (0.57--2.46)    0.96                                     1.15 (0.59--2.30)         0.68                
                                                                         Radiculopathy            0 (0)                                                               6 (21.4)                                                      6 (21.4)                                      
                                                                         Myelopathy               16 (10.3)                                                           36 (23.2)                                                     46 (29.7)                                     
                                                                         Motor deficit            14 (10.6)             1.04 (0.40--2.94)       0.94                  33 (25.0)            1.57 (0.75--3.48)   0.33                 40 (30.3)                 1.25 (0.64--2.49)   0.52
  Comorbidities                                                                                                                                                                                                                                                                   
                                         Diabetes                        6 (18.2)                 2.33 (0.77--6.39)     0.11                    8 (24.2)              1.07 (0.42--2.49)    0.69                11 (33.3)            1.25 (0.55--2.74)         0.58                
                                         Coronary artery disease         3 (21.4)                 2.61 (0.55--9.39)     0.17                    5 (35.7)              1.94 (0.57--5.96)    0.19                6 (42.9)             1.90 (0.60--5.73)         0.26                
                                         Psychiatric disorder            10 (14.5)                1.98 (0.77--5.09)     0.15                    14 (20.3)             0.79 (0.38--1.58)    0.52                22 (31.9)            1.23 (0.64--2.32)         0.52                
                                         Chronic renal disease           1 (8.3)                  0.78 (0.04--4.36)     0.82                    4 (33.3)              1.72 (0.44--5.75)    0.32                4 (33.3)             1.22 (0.31--4.04)         0.76                
                                         Chronic pulmonary disease       0 (0)                    0 (0--NaN)            0.08                    4 (33.3)              0.52 (0.12--1.63)    0.39                4 (33.3)             0.37 (0.08--1.14)         0.12                
                                         Arthritis                       2 (6.3)                  1.81 (0.55--5.14)     0.28                    6 (18.8)              0.73 (0.26--1.79)    0.97                10 (31.3)            1.11 (0.47--2.48)         0.80                
                                         Osteoporosis                    3 (15.0)                 2.47 (0.65--7.75)     0.14                    6 (30.0)              1.48 (0.50--3.97)    0.13                8 (40.0)             1.70 (0.63--4.37)         0.28                
  Preoperative medications                                                                                                                                                                                                                                                        
                                         Muscle relaxants                3 (7.7)                  0.67 (0.15--2.14)     0.54                    7 (17.9)              0.69 (0.26--1.62)    0.43                9 (23.1)             0.69 (0.29--1.50)         0.36                
                                         Antidepressant                  6 (16.7)                 1.96 (0.65--5.32)     0.20                    4 (10.8)              0.35 (0.10--0.95)    0.06                10 (27.0)            0.89 (0.38--1.93)         0.77                
                                         Antianxiety                     7 (21.2)                 1.19 (0.32--3.53)     0.77                    9 (26.5)              1.28 (0.52--2.90)    0.72                11 (32.4)            1.21 (0.53--2.64)         0.64                
                                         Narcotics                       15 (15.0)                1.47 (0.58--3.91)     0.43                    28 (27.7)             1.76 (0.90--3.53)    0.10                35 (34.7)            1.76 (0.94--3.33)         0.07                
  Preoperative radiographic parameters                                                                                                                                                                                                                                            
                                         Cervical lordosis                                        1.01 (0.98--1.05)     0.59                                          1.00 (0.97--1.02)    0.91                                     1.00 (0.98--1.02)         0.97                
                                         T1 slope                                                 1.01 (0.98--1.04)     0.26                                          1.01 (0.98--1.04)    0.48                                     1.00 (0.98--1.04)         0.67                
                                         cSVA                                                     1.03 (1.00--1.06)     0.04                                          1.01 (0.99--1.03)    0.17                                     1.02 (0.99--1.04)         0.11                
                                         Chin-brow vertical angle                                 1.06 (0.94--1.19)     0.30                                          0.98 (0.90--1.06)    0.67                                     1.01 (0.93--1.08)         0.89                
                                         Proximal junctional angle                                1.00 (0.95--1.05)     0.98                                          0.99 (0.96--1.01)    0.43                                     0.99 (0.97--1.02)         0.58                
                                         Distal junctional angle                                  1.04 (0.94--1.16)     0.50                                          1.02 (0.95--1.10)    0.63                                     1.00 (0.95--1.07)         0.90                
                                         Sacral slope                                             1.04 (0.98--1.09)     0.18                                          1.00 (0.96--1.04)    0.97                                     1.02 (0.99--1.05)         0.38                
                                         Pelvic incidence                                         1.01 (0.97--1.06)     0.56                                          1.01 (0.98--1.04)    0.64                                     1.01 (0.98--1.04)         0.40                
                                         Pelvic tilt                                              0.97 (0.92--1.03)     0.40                                          1.00 (0.97--1.04)    0.84                                     1.00 (0.96--1.03)         0.80                
                                         Lumbar lordosis                                          1.03 (0.99--1.07)     0.17                                          1.01 (0.98--1.04)    0.51                                     1.01 (0.99--1.04)         0.34                
                                         Thoracic kyphosis                                        1.07 (1.02--1.14)     0.01                                          1.03 (0.99--1.07)    0.14                                     1.03 (0.99--1.06)         0.10                
                                         SVA                                                      0.99 (0.98--1.01)     0.34                                          1.00 (0.99--1.01)    0.99                                     1.00 (0.99--1.01)         0.89                
  Procedure                                                                                                                                                                                                                                                                       
                                         Laminectomy performed           20 (11.0)                0.54 (0.13--3.71)     0.45                    43 (23.4)             1.52 (0.38--10.17)   0.59                54 (29.3)            1.25 (0.36--5.78)         0.74                
                                         Length of fusion                                         1.19 (0.94--1.51)     0.14                                          1.03 (0.86--1.22)    0.78                                     1.05 (0.90--1.23)         0.54                
                                         Estimated blood loss (per mL)                            1.001 (1.00--1.002)   0.004                                         1.00 (1.00--1.00)    0.22                                     1.0005 (1.00003--1.001)   0.11                
                                                                         ≤ 500 mL                 13 (7.7)              Ref                     Ref                   35 (20.8)            Ref                 Ref                  43 (25.6)                 Ref                 Ref
                                                                         \> 500 mL                7 (25.0)              3.97 (1.36--10.91)      0.01                  10 (35.7)            2.11 (0.87--0.91)   0.09                 15 (50.0)                 2.91 (1.28--6.64)   0.01
  Operative time (min)                                                   1.007 (1.003--1.01)      0.004                                         1.003 (1.00--1.006)   0.10                                     1.004 (1.00--1.01)   0.03                                          

Values presented as number (%) unless otherwise indicated.

OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists physical status classification; CAD, coronary artery disease; cSVA, cervical sagittal vertical axis; SVA, sagittal vertical axis; N/A, not applicable; NaN, not a number.

###### 

Multivariate logistic regression of risk factors for 30-day medical complication

  Risk factor             Odds ratio   95% CI   p-value   
  ----------------------- ------------ -------- --------- --------------------------------------------------------
  Impaired ambulation     2.27         1.14     4.50      0.02^[\*](#tfn2-ns-1938198-099){ref-type="table-fn"}^
  Thoracic kyphosis (°)   1.08         1.03     1.14      0.004^[\*](#tfn2-ns-1938198-099){ref-type="table-fn"}^
  EBL over 500 mL         3.67         1.15     11.27     0.02^[\*](#tfn2-ns-1938198-099){ref-type="table-fn"}^

CI, confidence interval; EBL, estimated blood loss.

p\<0.05.

###### 

Multivariate logistic regression of risk factors for 30-day surgical complication

  Risk factor            Odds ratio   95% CI   p-value   
  ---------------------- ------------ -------- --------- -------------------------------------------------------
  Antidepressant use     0.21         0.05     0.64      0.01^[\*](#tfn3-ns-1938198-099){ref-type="table-fn"}^
  Narcotic use           2.43         1.17     5.18      0.02^[\*](#tfn3-ns-1938198-099){ref-type="table-fn"}^
  Operative time (min)   1.005        1.00     1.01      0.03^[\*](#tfn3-ns-1938198-099){ref-type="table-fn"}^

CI, confidence interval.

p\<0.05.

###### 

Multivariate logistic regression of risk factors for 30-day overall complication

  Risk factor       Odds ratio   95% CI    p-value   
  ----------------- ------------ --------- --------- -------------------------------------------------------
  Narcotic use      1.97         1.03      3.82      0.04^[\*](#tfn4-ns-1938198-099){ref-type="table-fn"}^
  EBL over 500 mL   1.0007       1.00002   1.002     0.03^[\*](#tfn4-ns-1938198-099){ref-type="table-fn"}^

CI, confidence interval; EBL, estimated blood loss.

p\<0.05.
